Beneficial therapeutic effect of plasmapheresis after unsuccessful treatment with corticosteroids in two patients with severe toxic epidermal necrolysis

Therapeutic Apheresis and Dialysis

Volumn 14, Issue 3, 2010, Pages 354-357

  Szczeklik, Wojciech ^a   Nowak, Ilona ^a   Seczynska, Bozena ^a   Sega, Aurelia ^a   Krolikowski, Wieslaw ^a   Musial, Jacek ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Corticosteroids; Drug hypersensitivity; Lyell's syndrome; Plasmapheresis; Toxic epidermal necrolysis

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; C REACTIVE PROTEIN; CLARITHROMYCIN; CORTICOSTEROID; DEXAMETHASONE; METHYLPREDNISOLONE; OMEPRAZOLE; PARACETAMOL; PSEUDOEPHEDRINE; SALAZOSULFAPYRIDINE; GLUCOCORTICOID;

ADULT; ANEMIA; ARTICLE; BLURRED VISION; BRONCHITIS; CASE REPORT; CATHETER REMOVAL; CORNEA ULCER; DRUG MEGADOSE; DRUG WITHDRAWAL; EPITHELIZATION; ERYTHEMA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; HUMAN; HYPERGLYCEMIA; INTENSIVE CARE; LEUKOPENIA; MUCOSA INFLAMMATION; PHARYNGITIS; PLASMAPHERESIS; PRIORITY JOURNAL; PSORIASIS; SEIZURE; SEPSIS; STAPHYLOCOCCUS AUREUS; TOXIC EPIDERMAL NECROLYSIS; XEROPHTHALMIA; PATHOPHYSIOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; STEVENS-JOHNSON SYNDROME; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; FEMALE; GLUCOCORTICOIDS; HUMANS; PLASMAPHERESIS; SEVERITY OF ILLNESS INDEX; STEVENS-JOHNSON SYNDROME; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77952897823     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2009.00800.x     Document Type: Article

References (13)

1. Chave TA, Mortimer NJ, Sladden MJ, Hall AP, Hutchinson PE. Toxic epidermal necrolysis: current evidence, practical management and future directions. Br J Dermatol 2005 153 : 241 253.
2. Roujeau JC, Kelly JP, Naldi L et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995 333 : 1600 1607.
3. Mukasa Y, Craven N. Management of toxic epidermal necrolysis and related syndromes. Postgrad Med J 2008 84 : 60 5.
4. Yamada H, Takamori K. Status of plasmapheresis for the treatment of toxic epidermal necrolysis in Japan. Ther Apher Dial 2008 12 : 355 359.
5. Egan CA, Grant WJ, Morris SE, Saffle JR, Zone JJ. Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis. J Am Acad Dermatol 1999 40 : 458 461.
6. Sakellariou G, Koukoudis P, Karpouzas J et al. Plasma exchange (PE) treatment in drug-induced toxic epidermal necrolysis (TEN). Int J Artif Organs 1991 14 : 634 638.
7. Wolkenstein P, Latarjet J, Roujeau JC et al. Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet 1998 352 : 1586 1589.
8. Stables GI, Lever RS. Toxic epidermal necrolysis and systemic corticosteroids. Br J Dermatol 1993 128 : 357.
9. Halebian PH, Corder VJ, Madden MR, Finklestein JL, Shires GT. Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids. Ann Surg 1986 204 : 503 512.
10. Pereira FA, Mudgil AV, Rosmarin DM. Toxic epidermal necrolysis. J Am Acad Dermatol 2007 56 : 181 200.
11. Yamada H, Takamori K, Yaguchi H, Ogawa H. A study of the efficacy of plasmapheresis for the treatment of drug induced toxic epidermal necrolysis. Ther Apher 1998 2 : 153 156.
12. Szczepiorkowski ZM, Bandarenko N, Kim HC et al. Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 2007 22 : 106 175.
13. Furubacke A, Berlin G, Anderson C, Sjoberg F. Lack of significant treatment effect of plasma exchange in the treatment of drug-induced toxic epidermal necrolysis? Intensive Care Med 1999 25 : 1307 1310.